Oxidative stress in cystic fibrosis patients with Burkholderia cenocepacia airway colonization: relation of 8-isoprostane concentration in exhaled breath condensate to lung function decline
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Burkholderia cenocepacia * MeSH
- Time Factors MeSH
- Cystic Fibrosis complications metabolism physiopathology MeSH
- Dinoprost analogs & derivatives metabolism MeSH
- Adult MeSH
- Burkholderia Infections complications microbiology MeSH
- Humans MeSH
- Young Adult MeSH
- Opportunistic Infections * MeSH
- Oxidative Stress * MeSH
- Respiratory Function Tests MeSH
- Forced Expiratory Volume MeSH
- Exhalation MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- 8-epi-prostaglandin F2alpha MeSH Browser
- Dinoprost MeSH
The association between oxidative stress and neutrophilic inflammation in cystic fibrosis (CF) lung disease is well recognized. 8-Isoprostane is a product of non-enzymatic oxidation of arachidonic acid. The aim of the present study was to examine the relationship between lung function decline and 8-isoprostane concentrations in exhaled breath condensate (EBC) in CF patients with Burkholderia cenocepacia airway colonization. Concentrations of 8-isoprostane in EBC were measured in 24 stable CF patients with B. cenocepacia airway colonization. The median (interquartile range) age of the cohort was 23.9 (22.0; 26.6) years. All patients underwent clinical examinations and pulmonary function tests at the time of EBC collection and in 1-, 3-, and 5-year intervals. 8-Isoprostane concentrations in EBC correlated to 1- and 3-year declines of forced expiratory volume in 1 s (FEV1) with r(S) values of -0.511 (p = 0.0011) and -0.495 (p = 0.016), respectively. In multiple regression analysis, 8-isoprostane concentrations in EBC were the only independent predictor for 1-year FEV1 decline (p = 0.01). When the median value of 8-isoprostane concentration in EBC (10.0 pg/mL) was used as a cutoff, subgroups of patients with lower and higher level of oxidative stress had significantly different median (interquartile range) FEV1 declines in 1-year interval, -2.4% (-5.3; 0.8) and -7.3% (-10.3; -5.8) predicted (p = 0.009). In conclusion, 8-isoprostane concentrations in EBC correlated to short-term lung function decline in CF patients with B. cenocepacia airway colonization. This correlation reflects the role of oxidative stress in CF lung pathogenesis and contributes to prediction of prognosis in these patients.
See more in PubMed
Chest. 2006 Feb;129(2):431-437 PubMed
J Clin Microbiol. 2005 Sep;43(9):4665-73 PubMed
Biochim Biophys Acta. 2012 May;1822(5):690-713 PubMed
Am J Respir Crit Care Med. 2012 Nov 1;186(9):857-65 PubMed
Clin Microbiol Infect. 2010 Jul;16(7):821-30 PubMed
Am J Epidemiol. 2001 Feb 15;153(4):345-52 PubMed
Arch Biochem Biophys. 2002 Oct 1;406(1):33-9 PubMed
Semin Respir Crit Care Med. 2009 Oct;30(5):596-610 PubMed
J Pediatr. 1984 Feb;104(2):206-10 PubMed
Cas Lek Cesk. 2010;149(4):173-7 PubMed
Eur Respir J. 2005 Sep;26(3):523-48 PubMed
Thorax. 2000 Feb;55(2):138-42 PubMed
Chest. 2004 Jan;125(1 Suppl):1S-39S PubMed
J Cyst Fibros. 2012 Sep;11(5):440-5 PubMed
Eur Respir J. 1996 Feb;9(2):334-9 PubMed
Respir Care. 2009 May;54(5):595-605 PubMed
Eur Respir J. 1998 Feb;11(2):377-83 PubMed
Cell Microbiol. 2009 Feb;11(2):208-16 PubMed
Respirology. 2007 Jan;12(1):63-9 PubMed
N Engl J Med. 1992 Apr 30;326(18):1187-91 PubMed
J Cyst Fibros. 2012 Sep;11(5):405-11 PubMed
Am J Respir Crit Care Med. 2007 Nov 15;176(10):957-69 PubMed
Free Radic Biol Med. 2008 Sep 15;45(6):913-9 PubMed
Vnitr Lek. 2009 Jun;55(6):542-8 PubMed
Eur Respir J. 2005 Aug;26(2):319-38 PubMed
Eur Respir J. 1999 Jan;13(1):103-6 PubMed
Am J Respir Crit Care Med. 2002 Dec 15;166(12 Pt 1):1550-5 PubMed
Free Radic Biol Med. 1995 Apr;18(4):801-6 PubMed
Eur Respir J. 2012 Jul;40(1):61-6 PubMed
Lipids. 1999 Jun;34(6):551-6 PubMed
J Clin Microbiol. 2010 Jan;48(1):34-40 PubMed
Thorax. 2000 Mar;55(3):205-9 PubMed
